MSF calls for equitable access to TB drugs and diagnostics in first-ever plenary session on access at the TB Union Conference
November 13, 2024Bali/Geneva, 13 November 2024 – At the premier global conference on tuberculosis (TB), the annual Union World Conference on Lung Health, taking place in Bali, Indonesia, Christophe Perrin, TB Advocacy Pharmacist at MSF’s Access Campaign, was invited to present on...
Read more
MSF and global TB activists take stage at annual TB conference
November 13, 2024Activists present ‘Time for $5’ petition signed by over 206,000 people asking US corporations Cepheid and Danaher to drop test prices Bali/Geneva, 12 November 2024 – At the annual TB Union Conference, taking place in Bali, Indonesia, over 70 TB activists, including...
Read more
Ahead of World Diabetes Day, pharmaceutical corporations Eli Lilly, Novo Nordisk, and Sanofi must make insulin pens available at $1 per pen
November 11, 202480% of people with diabetes live in low- and middle-income countries, where access to insulin pens is extremely limited due primarily to high prices. Geneva/Johannesburg, 11 November 2024 – Ahead of World Diabetes Day, Médecins Sans Frontières/Doctors Without Borders (MSF) called on...
Read more
‘Time for $5’ campaign to deliver 206,937 signatures to US corporation Danaher in Washington, DC, demanding a $5 price for their medical tests
October 17, 2024US test maker Cepheid and parent corporation Danaher have ignored global calls for price reductions and have broken their promise from one year ago to be transparent about what it costs to make their medical tests Washington, DC, 17 October...
Read more
MSF calls for urgent action as governments and donors are failing children with TB
October 15, 2024Too many children with TB are neither tested nor treated, with many countries failing at the first hurdle: updating policy guidelines in line with WHO recommendations. Geneva, 15 October 2024 - A new report released today by Médecins Sans Frontières/Doctors Without...
Read more
Activists at AIDS2024 demand: Break Gilead’s Lenacapavir monopoly
July 23, 2024Gilead’s Price is 1,000 Times the Target Generic Price for 100% Effective Prevention ShotMunich, 23 July 2024: Today at the International AIDS Conference, a coalition of activists, including Médecins Sans Frontières (MSF), called for immediate global action to break Gilead’s...
Read more
MSF welcomes Indian Patent Office’s rejection of J&J’s application for paediatric formulation of lifesaving TB drug
July 17, 2024Mumbai, 17 July 2024 – On Friday 5 July 2024, the “pre-grant opposition” filed in December 2020 by The Delhi Network of Positive People (DNP+) and a Mumbai-based tuberculosis (TB) survivor Ganesh Acharya, and supported by Médecins Sans Frontières/Doctors Without...
Read more
MSF and Health Justice Initiative welcome J&J’s withdrawal of patents on lifesaving TB drug in South Africa
July 8, 2024The patent withdrawal is a result of an unprecedented investigation by South Africa’s Competition Commission into J&J We welcome today’s news that following the Competition Commission’s investigation initiation into anti-competitive practice, J&J has officially withdrawn its secondary patents in South...
Read more
Secrets Cost Lives: Transparency and access to medical products
July 5, 2024As an international medical humanitarian organisation, Médecins Sans Frontières/Doctors Without Borders (MSF) has repeatedly witnessed how the world’s most vulnerable people are left without access to the lifesaving medicines, diagnostics tests and vaccines they need. Ensuring access to these medical...
Read more
Danaher continues to charge exorbitant prices for lifesaving medical tests despite urgent demands for price reductions by several Ministries of Health
June 18, 2024Geneva, 17 June 2024 - In September 2023, the US corporation Danaher, which owns diagnostics maker Cepheid, announced a price reduction of the primary GeneXpert test used to diagnose tuberculosis (TB), from US$9.98 to $7.97, amid pressure from TB activists....
Read more
Urgent call for Europe to improve treatment access for tuberculosis: Many TB medicines and formulations accessible in lower- and middle-income countries remain unaffordable or unavailable in Europe
June 7, 2024Berlin, 6 June 2024: As the World Health Organization (WHO) concluded a meeting with European health officials and civil society to improve access to tuberculosis (TB) medicines in the European Union (EU)/European Economic Area (EEA), Médecins Sans Frontières/Doctors Without Borders...
Read more
Gavi’s next strategy must make sure to reach the 10 million children in fragile and humanitarian settings who are missing vaccines
June 4, 2024Where are we now? This week, on 6-7 June 2024, the Board of Gavi, the Vaccine Alliance, is meeting in Geneva to approve and endorse the one-page framework for Gavi 6.0, which outlines its strategy for the five-year period from...
Read more
